Walleye Capital
IDXX icon

Walleye Capital’s Idexx Laboratories IDXX Stock Holding History

Walleye Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-300
Closed -$169K – 4933
2026
Q1 		$169K Buy
300
+100
+50% +$64.1K ﹤0.01% 3432
2025
Q4 		$135K Buy
+200
New +$136K ﹤0.01% 3738
2025
Q3 		– Sell
-200
Closed -$107K – 4789
2025
Q2 		$107K Sell
200
-400
-67% -$191K ﹤0.01% 3745
2025
Q1 		$252K Sell
600
-1,500
-71% -$651K ﹤0.01% 3088
2024
Q4 		$868K Buy
2,100
+1,300
+163% +$570K ﹤0.01% 2508
2024
Q3 		$404K Buy
800
+600
+300% +$291K ﹤0.01% 3495
2024
Q2 		$97.4K Sell
200
-5,700
-97% -$2.86M ﹤0.01% 4731
2024
Q1 		$3.19M Buy
5,900
+1,300
+28% +$710K 0.01% 1649
2023
Q4 		$2.55M Sell
4,600
-5,600
-55% -$2.63M 0.01% 1601
2023
Q3 		$4.46M Buy
10,200
+1,900
+23% +$947K 0.01% 1116
2023
Q2 		$4.17M Buy
8,300
+8,200
+8,200% +$3.93M 0.02% 849
2023
Q1 		$50K Buy
+100
New +$47.9K ﹤0.01% 3207

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Walleye Capital's IDXX Position: Q2 2026 in Review

Walleye Capital sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 170 shares — an estimated $95.5K sold.

Walleye Capital first reported a position in IDXX in Q3 2021 and held it in 12 quarters. The position peaked at $15.6M in Q3 2024. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Walleye Capital reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • Walleye Capital sold 170 Idexx Laboratories shares in Q2 2026, an estimated $95.5K.
  • Walleye Capital first reported a position in Idexx Laboratories in Q3 2021 and held it in 12 quarters.
  • Walleye Capital's Idexx Laboratories position peaked at $15.6M in Q3 2024.
  • 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.